![Luciana Borio](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Luciana Borio
Directeur/Membre du Conseil chez
EAGLE PHARMACEUTICALS, INC.
Fortune : 627 445 $ au 31/05/2026
Profil
Luciana Borio is currently an Independent Director at Eagle Pharmaceuticals, Inc. and Insulet Corp.
since 2021.
Also since 2021, serving as Director at Paradigm Health, Inc., Venture Partner at ARCH Venture Partners LLC, and Trustee at Noblis, Inc. Formerly, Director-Medical & Biodefense Preparedness Policy at the National Security Council from 2017 to 2019.
Senior Vice President at In-Q-Tel, Inc. from 2019 to 2020.
Senior Associate at Johns Hopkins Center For Health Security from 2003 to 2008.
Chief Scientist at the US Food & Drug Administration from 2015 to 2017.
Education includes undergraduate studies at George Washington University and a doctorate from George Washington University School of Medicine & Health.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
INSULET CORPORATION 0,01 % | 03/06/2026 | 4 329 ( 0,01 % ) | 627 445 $ | 31/05/2026 |
Postes actifs de Luciana Borio
| Sociétés | Poste | Début |
|---|---|---|
| EAGLE PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 28/04/2021 |
| INSULET CORPORATION | Directeur/Membre du Conseil | 18/10/2021 |
Noblis, Inc.
 Noblis, Inc. Miscellaneous Commercial ServicesCommercial Services Provides science based technology and strategy consulting services | Directeur/Membre du Conseil | 25/10/2021 |
ARCH Venture Partners LLC
 ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners invests in disruptive science companies located in the United States. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with a minimum investment size of $0.05 million and also makes co-investments. | Private Equity Investor | 01/12/2021 |
Paradigm Health, Inc.
 Paradigm Health, Inc. Packaged SoftwareTechnology Services Develops platform for clinical research | Directeur/Membre du Conseil | - |
Anciens postes connus de Luciana Borio
| Sociétés | Poste | Fin |
|---|---|---|
In-Q-Tel, Inc.
 In-Q-Tel, Inc. Financial ConglomeratesFinance Alternative investment manager | Corporate Officer/Principal | 01/01/2020 |
National Security Council | Corporate Officer/Principal | 01/01/2019 |
US Food & Drug Administration
 US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Corporate Officer/Principal | 01/01/2017 |
Johns Hopkins Center For Health Security
 Johns Hopkins Center For Health Security Miscellaneous Commercial ServicesCommercial Services Conducts research and policy analysis | Corporate Officer/Principal | 01/10/2008 |
Formation de Luciana Borio
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
45
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners invests in disruptive science companies located in the United States. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with a minimum investment size of $0.05 million and also makes co-investments. | Finance |
Eagle Pharmaceuticals, Inc.
 Eagle Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercialize injectable products primarily in the metabolic critical care and oncology | Health Technology |
George Washington University
 George Washington University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Noblis, Inc.
Noblis, Inc. Miscellaneous Commercial ServicesCommercial Services Provides science based technology and strategy consulting services | Commercial Services |
Insulet Corp.
 Insulet Corp. Medical SpecialtiesHealth Technology Manufactures, develops and markets insulin infusion systems | Health Technology |
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Government |
In-Q-Tel, Inc.
In-Q-Tel, Inc. Financial ConglomeratesFinance Alternative investment manager | Finance |
Johns Hopkins Center For Health Security
Johns Hopkins Center For Health Security Miscellaneous Commercial ServicesCommercial Services Conducts research and policy analysis | Commercial Services |
National Security Council | |
George Washington University School of Medicine & Health
 George Washington University School of Medicine & Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Paradigm Health, Inc.
Paradigm Health, Inc. Packaged SoftwareTechnology Services Develops platform for clinical research | Technology Services |
